Latest News About - Vesicular stomatitis

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Monday, June 1, 2020

5:22:00 PM CEST

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
gl
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
nl
no
pap
pl
ps
pt
ro
ru
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Most reported countries (24h)

Theme countries

AlertLevel (24h)

Alert level graph

 Previous 14 days average

Alert level:
 high   medium   low

Quotes... Extracted quotes

Stephen Russell said: "We look forward to providing an update on the clinical development of Voyager-V1, including a new 5-arm Phase 2 study launched last month to evaluate Voyager-V1 in combination with Libtayo in multiple cancer indications," External link

benzinga Friday, May 29, 2020 2:18:00 PM CEST

Stephen Russell said: “We look forward to providing an update on the clinical development of Voyager-V1, including a new 5-arm Phase 2 study launched last month to evaluate Voyager-V1 in combination with Libtayo in multiple cancer indications,” External link

globenewswire Friday, May 29, 2020 1:33:00 PM CEST

Roger M Perlmutter said: "COVID-19 is an enormous scientific, medical, and global health challenge. Merck is collaborating with organizations around the globe to develop anti-infectives and vaccines that aim to alleviate suffering caused by SARS-CoV-2 infection," External link

openpr Friday, May 29, 2020 8:58:00 AM CEST

Mark Feinberg said: "We believe an rVSV-based vaccine strategy represents a promising approach to combating the novel coronavirus pandemic and look forward to implementing an accelerated development program, together with Merck, to evaluate the potential of our vaccine candidate against SARS-CoV-2. The collaboration between Merck and IAVI represents an innovative partnership model and approach to utilize our joint capabilities in complementary and synergistic ways to address this difficult global health challenge," External link

openpr Friday, May 29, 2020 8:58:00 AM CEST

Roger Perlmutter says: “Clearly, we have a lot of heft,” External link

sciencemag-org Thursday, May 28, 2020 4:43:00 AM CEST

Roger Perlmutter says: “Most vaccine projects fail—it’s very difficult to make a vaccine,” “So if I’m going to start making a vaccine, I’d like to be thoughtful about which vaccine platforms have the greatest likelihood of success” External link

sciencemag-org Thursday, May 28, 2020 4:43:00 AM CEST

Mark Feinberg says: “The multiple shots on goal analogy [for the COVID-19 vaccine pursuit] makes enormous sense here,” “With 100-some candidates, not all of them are going to advance to the clinic or be able to be produced at scale. There will have to be a rigorous, thoughtful, data-driven process to select the most promising ones” External link

sciencemag-org Thursday, May 28, 2020 4:43:00 AM CEST

Roger Perlmutter says: “When you start thinking about immunizing billions of people, the idea of having to track people down for boosters is very problematic,” “It’s not impossible, but you’d prefer not to do it” External link

sciencemag-org Thursday, May 28, 2020 4:43:00 AM CEST

Lawrence Corey says: “I’m delighted to see them undertake two novel platforms for potential COVID vaccine development,” External link

sciencemag-org Thursday, May 28, 2020 4:43:00 AM CEST

Roger Perlmutter agrees: “ordinarily you prefer not to advance a mutagen,” External link

sciencemag-org Thursday, May 28, 2020 4:43:00 AM CEST

Roger Perlmutter says: “One of the things I think is disturbing is I don’t want people to imagine that—not that they would—that Merck is coming in now and it’s all going to get taken care of in 12 months,” “It’s not. These things take a long time” External link

sciencemag-org Thursday, May 28, 2020 4:43:00 AM CEST

Kenneth Frazier noted: “COVID-19 is a global challenge and requires global solutions. MSD intends to make any vaccine or medicine we develop for this pandemic broadly accessible and affordable globally, and we are working now to accomplish this goal as quickly as possible,” External link

newsnow-co-uk Wednesday, May 27, 2020 10:24:00 AM CEST

Kenneth Frazier said: “We will ensure that all of these programmes have the resources, attention and focus they need and that the Covid-19 pandemic demands” External link

newsnow-co-uk Wednesday, May 27, 2020 9:21:00 AM CEST

Roger Perlmutter says: “Clearly, we have a lot of heft,” External link

sciencemag-org Tuesday, May 26, 2020 9:39:00 PM CEST

Roger Perlmutter says: “Most vaccine projects fail—it’s very difficult to make a vaccine,” “So if I’m going to start making a vaccine, I’d like to be thoughtful about which vaccine platforms have the greatest likelihood of success” External link

sciencemag-org Tuesday, May 26, 2020 9:39:00 PM CEST

Mark Feinberg says: “The multiple shots on goal analogy [for the COVID-19 vaccine pursuit] makes enormous sense here,” “With 100-some candidates, not all of them are going to advance to the clinic or be able to be produced at scale. There will have to be a rigorous, thoughtful, data-driven process to select the most promising ones” External link

sciencemag-org Tuesday, May 26, 2020 9:39:00 PM CEST

Roger Perlmutter says: “When you start thinking about immunizing billions of people, the idea of having to track people down for boosters is very problematic,” “It’s not impossible, but you’d prefer not to do it” External link

sciencemag-org Tuesday, May 26, 2020 9:39:00 PM CEST

Lawrence Corey says: “I’m delighted to see them undertake two novel platforms for potential COVID vaccine development,” External link

sciencemag-org Tuesday, May 26, 2020 9:39:00 PM CEST

Roger Perlmutter agrees: “ordinarily you prefer not to advance a mutagen,” External link

sciencemag-org Tuesday, May 26, 2020 9:39:00 PM CEST

Roger Perlmutter says: “One of the things I think is disturbing is I don’t want people to imagine that—not that they would—that Merck is coming in now and it’s all going to get taken care of in 12 months,” “It’s not. These things take a long time” External link

sciencemag-org Tuesday, May 26, 2020 9:39:00 PM CEST

Roger M Perlmutter said: “Merck is collaborating with organizations around the globe to develop anti-infectives and vaccines that aim to alleviate suffering caused by SARS-CoV-2 infection,” External link

news-yahoo Tuesday, May 26, 2020 4:18:00 PM CEST

Roger M Perlmutter stated: “Since preclinical studies demonstrate that EIDD-2801 has potent antiviral properties against multiple coronavirus strains including SARS-CoV-2, we are eager to advance the next phase of clinical studies as rapidly and responsibly as possible,” External link

genengnews Tuesday, May 26, 2020 4:13:00 PM CEST

Kenneth Frazier said: “We start with a platform we understand,” “We understand how it behaves, how to make it, how to scale it up, because we have experiencing with that platform” External link

alarabiya-en Tuesday, May 26, 2020 3:49:00 PM CEST

Kenneth Frazier said (about Roger Perlmutter): “We’ll get back to normal at some point,” “I’m totally confident in the high quality people who we have behind me and behind Roger Perlmutter” External link

alarabiya-en Tuesday, May 26, 2020 3:49:00 PM CEST

Kenneth Frazier said: “We start with a platform we understand,” “We understand how it behaves, how to make it, how to scale it up, because we have experiencing with that platform” External link

newsnow-co-uk Tuesday, May 26, 2020 2:14:00 PM CEST

Kenneth Frazier said (about Roger Perlmutter): “We’ll get back to normal at some point,” “I’m totally confident in the high quality people who we have behind me and behind Roger Perlmutter” External link

newsnow-co-uk Tuesday, May 26, 2020 2:14:00 PM CEST

Ken Frazier said: “We’ve got to immunize seven billion people on the planet,” “If you have a dose that gives you a high amount of neutralizing antibodies with a single dose, that’s a much better, more simple to deploy vaccine, than one that requires multiple doses” External link

barrons Tuesday, May 26, 2020 1:20:00 PM CEST

Ken Frazier said: “We simply would try to make sure we can make this available to whoever needs it,” “We intend to make it broadly available in a way that people can afford wherever they are in the world” External link

barrons Tuesday, May 26, 2020 1:20:00 PM CEST

Ken Frazier said: “It’s a huge head start if you’ve handled the vaccine, you know how to scale it up,” External link

barrons Tuesday, May 26, 2020 1:20:00 PM CEST

Ken Frazier said: “We know from the work that’s been done already that it’s very potent, that it blocks the reproduction of many RNA viruses, including SARS-CoV-2,” External link

barrons Tuesday, May 26, 2020 1:20:00 PM CEST

Roger M Perlmutter said: “COVID-19 is an enormous scientific, medical, and global health challenge. Merck is collaborating with organizations around the globe to develop anti-infectives and vaccines that aim to alleviate suffering caused by SARS-CoV-2 infection,” External link

4-traders Tuesday, May 26, 2020 12:58:00 PM CEST

Mark Feinberg said: “We believe an rVSV-based vaccine strategy represents a promising approach to combating the novel coronavirus pandemic and look forward to implementing an accelerated development program, together with Merck, to evaluate the potential of our vaccine candidate against SARS-CoV-2. The collaboration between Merck and IAVI represents an innovative partnership model and approach to utilize our joint capabilities in complementary and synergistic ways to address this difficult global health challenge,” External link

4-traders Tuesday, May 26, 2020 12:58:00 PM CEST

Mark Feinberg said: “The fact that regulatory authorities are familiar with this platform is a big asset for our program, as well as for their review,” External link

statnews Tuesday, May 26, 2020 12:52:00 PM CEST

Roger Perlmutter said: “What we’ve learned is that these replicating vectors tend to be more effective,” External link

statnews Tuesday, May 26, 2020 12:52:00 PM CEST

Roger Perlmutter said: “We have a global operation, so we’re not limited to the U.S.,” “I fear that with the substantial relaxation that is taking place also as we speak, that there will be no shortage, unfortunately, of Covid-19 patients in the United States” External link

statnews Tuesday, May 26, 2020 12:52:00 PM CEST

Most associated names

Daily number of articles in this category

Trend data not available for this selection.